Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24).

作者: Joachim Kuhn , Martina Schnölzer , Sylvia Schön , Sandra Müller , Christian Prante

DOI: 10.1016/J.BBRC.2005.05.087

关键词:

摘要: Abstract Human basic fibroblast growth factor (bFGF) is a heparin-binding containing G-S-G-motif which potential recognition sequence of xylosyltransferase I (XT-I). Here, we show that the recombinant human bFGF was xylosylated in vitro by XT-I and fragment (1–24) good acceptor ( K m  = 20.8 μM for native  = 22.3 μM XT-I). MALDI MALDI-PSD time-of-flight mass spectrometric analyses protein demonstrate transfer xylose to serine residue amino terminal end bFGF. The peptide well suitable as an substrate can be used radiochemical assay measure activity cell culture supernatant body fluids, respectively. Furthermore, could interacts strongly with heparin this glycosaminoglycan predominantly non-competitive inhibitor enzyme using acceptor.

参考文章(41)
Nicholas N. NISSEN, Ravi SHANKAR, Richard L. GAMELLI, Ashok SINGH, Luisa A. DiPIETRO, Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochemical Journal. ,vol. 338, pp. 637- 642 ,(1999) , 10.1042/BJ3380637
Joachim Kuhn, Katharina Mölle, Thomas Brinkmann, Christian Götting, Knut Kleesiek, High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase. Journal of Biotechnology. ,vol. 103, pp. 191- 196 ,(2003) , 10.1016/S0168-1656(03)00102-0
Francesco Facchiano, Alessandro Lentini, Vincenzo Fogliano, Salvatore Mancarella, Cosmo Rossi, Antonio Facchiano, Maurizio C. Capogrossi, Sugar-Induced Modification of Fibroblast Growth Factor 2 Reduces Its Angiogenic Activity in Vivo American Journal of Pathology. ,vol. 161, pp. 531- 541 ,(2002) , 10.1016/S0002-9440(10)64209-5
Pnina Bashkin, Susan Doctrow, Michael Klagsbrun, Carl Magnus Svahn, Judah Folkman, Israel Vlodavsky, Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry. ,vol. 28, pp. 1737- 1743 ,(1989) , 10.1021/BI00430A047
Tetsuhito Kojima, Akira Katsumi, Tomio Yamazaki, Takashi Muramatsu, Tetsuro Nagasaka, Kazuoki Ohsumi, Hidehiko Saito, Human Ryudocan from Endothelium-like Cells Binds Basic Fibroblast Growth Factor, Midkine, and Tissue Factor Pathway Inhibitor Journal of Biological Chemistry. ,vol. 271, pp. 5914- 5920 ,(1996) , 10.1074/JBC.271.10.5914
A. Rapraeger, A. Krufka, B. Olwin, Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. ,vol. 252, pp. 1705- 1708 ,(1991) , 10.1126/SCIENCE.1646484
Thomas Brinkmann, Christian Weilke, Knut Kleesiek, Recognition of Acceptor Proteins by UDP-D-xylose Proteoglycan Core Protein β-D-Xylosyltransferase Journal of Biological Chemistry. ,vol. 272, pp. 11171- 11175 ,(1997) , 10.1074/JBC.272.17.11171